Enanta Pharmaceuticals (9EP.STU) Q1 2026 Earnings

9FebConfirmed
Q1 2026
-0.64
-0.55
-0.45
-0.35

Details

Expected EPS
-0.64478330076
Actual EPS
-0.3527748
Surprise EPS
0.29
Surprise Percent
+45.29%

Description

Enanta Pharmaceuticals (9EP.STU) has reported earnings of -0.3527748 per share for Q1 2026.

0 Comments

Share your thoughts